Pharmacology Quiz
19 questions · no time limit
0:00
HEMATOLOGY PHARMACOLOGY
Question 1 of 19
No time limit
Current
Answered
Flagged
Not seen
A patient with metastatic non-small cell lung cancer is receiving palliative chemotherapy. The patient develops symptomatic anemia with a hemoglobin of 8.5 g/dL. Before initiating an erythropoiesis-stimulating agent (ESA), what is the most critical discussion point and consideration according to the FDA's black box warning?
YOUR PROGRESS
19
QUESTIONS
Ready when you are
Answer in any order. Your progress shows here as you go.
QUESTIONS
KEYBOARD
Pick an answer ABCD
Next question ↵→
Previous ←
Flag for review F
Answers save as you go · flagged questions come back at the end